International Journal of Biological Macromolecules APC and Open Access: What Elsevier Charges and Your Coverage Options

IJBM is hybrid. Two paths are available:

1. Subscription track (default): Your article goes behind Elsevier's ScienceDirect paywall. Readers access it through library subscriptions. You pay $0.
2. Open access track (optional): Your article is immediately free to read. You (or your funder/institution) pay the APC.

Biopolymer and macromolecule research has a large international author base, with particularly high submission volumes from China, India, and Iran. In many of these countries, institutional OA coverage is limited, and the subscription track remains the practical default. The article still gets the same DOI, peer review, Scopus indexing, and Web of Science listing.

For researchers whose funders don't mandate immediate open access, the subscription track is a genuinely free publication option. Most universities that produce macromolecule research maintain Elsevier ScienceDirect subscriptions, so your colleagues will still be able to read the paper.

IJBM is a core Elsevier title and is included in all Elsevier Read & Publish (R&P) agreements. Unlike Cell Press journals and Lancet titles, which are frequently carved out of these deals, IJBM gets full coverage.

If your institution participates:

1. Your paper is accepted.
2. Elsevier's system identifies your institutional affiliation during the rights and access step.
3. You're offered open access at no cost.
4. The APC is covered by the agreement.

Major Elsevier R&P agreements active in 2026:

The usual caveat applies: agreements cover the corresponding author's institution. If you're part of a multi-institutional collaboration, make sure the corresponding author is at a covered institution if APC coverage matters to your team.

Automatic waivers: Corresponding authors in Research4Life Group A countries (low-income nations) receive a full APC waiver. Group B countries get discounts, typically around 50%.

Case-by-case waivers: Elsevier accepts hardship waiver requests at acceptance. These are reviewed individually. Elsevier states that waiver decisions don't influence editorial outcomes.

No society discounts. IJBM doesn't have a sponsoring society offering member discounts. This is different from journals published by the American Chemical Society or the Royal Society of Chemistry where membership provides reduced rates.

Special issue waivers: Elsevier occasionally extends waiver offers through guest editors for special issues. IJBM runs many special issues, so these opportunities come up, but they shouldn't be factored into your baseline budget.

For Plan S compliance, select the CC BY license specifically. Elsevier also offers CC BY-NC-ND, which won't satisfy cOAlition S requirements. Pay attention to the license selection during the production workflow.

Green OA is available with a 12-month embargo. You can deposit the accepted manuscript in an institutional repository after the embargo period.

Broad macromolecule scope. IJBM covers proteins, polysaccharides, nucleic acids, and lipids. This breadth means your paper on chitosan nanoparticles appears alongside work on protein folding, DNA-binding molecules, and starch modification. The cross-pollination attracts citations from multiple subfields.

Rapid growth trajectory. IJBM's impact factor has grown from about 3.0 a decade ago to 7.7 today. This growth is partly due to scope expansion and partly due to publishing more review articles and special issues, which attract high citations. The growth trajectory matters because it suggests the journal may continue to climb, making a 2026 publication potentially more valuable over time.

High volume, moderate selectivity. Publishing over 4,500 articles per year means IJBM has a higher acceptance rate than journals like Biomacromolecules or Carbohydrate Polymers. For researchers who need a Q1 publication at a reasonable pace, this volume is an advantage. First decision time is typically 30-50 days, and total time to publication is 3-5 months.

Strong in applied biopolymer research. IJBM is particularly strong in applied areas: food packaging, drug delivery, wound healing materials, water treatment using biopolymers, and biodegradable materials. If your macromolecule work has a clear application, IJBM's reviewer community will appreciate and understand it.

Structural biology content. Despite the "macromolecules" name suggesting polymer chemistry, IJBM publishes substantial amounts of structural biology. Protein structure, enzyme characterization, and molecular dynamics simulations of biological macromolecules all fit the scope.

• No page charges beyond the optional APC
• No color figure fees. All figures are published in color online at no charge.
• Supplementary data hosted on ScienceDirect or Mendeley Data for free
• Reprints cost extra if needed
• VAT may apply for European authors, adding 15-25% to the APC
• Embargo for green OA is 12 months
• Graphical abstract encouraged. Not mandatory, but IJBM recommends graphical abstracts and they improve article discoverability on ScienceDirect.
• Highlights required. IJBM asks for 3-5 bullet point highlights summarizing the paper. These appear on ScienceDirect and help readers decide whether to read the full article.

If you're publishing in International Journal of Biological Macromolecules, the APC decision follows the standard Elsevier hybrid flow:

1. Does your funder require immediate open access? If yes, choose gold OA. Check for Elsevier R&P coverage.
2. Is your institution covered by an Elsevier deal? If yes, open access is free. Take it.
3. Neither applies? Publish via the subscription track. It costs nothing and your paper gets the same indexing, DOI, and peer review.

The more important question is whether IJBM is the right journal for your work. With an IF of 7.7 and Q1 ranking, it's a strong venue for biopolymer and macromolecule research. Reviewers expect clear characterization data, proper controls, and evidence of novelty beyond incremental improvements. For protein work, they want structural data. For polysaccharide applications, they want performance comparisons with existing materials.

If your work is specifically about polysaccharides and you're aiming for maximum impact, consider whether Carbohydrate Polymers (IF 10.7) is a better fit. If you need a broader biochemistry audience, journals like International Journal of Biological Chemistry or Biochemistry (ACS) may be alternatives, though at different price points and selectivity levels.

Whatever you decide, make sure your manuscript is polished before submission. Run a free readiness scan to catch the issues that lead to desk rejection, from incomplete statistical analyses to figure quality problems that reviewers flag in their first pass.

For more on journal impact factors and what they mean for your submission strategy, see our detailed guide. You might also find our overview of how open access fees work across publishers useful for comparing costs across your shortlisted journals.